In a report released yesterday, David Risinger from SVB Securities maintained a Hold rating on Gilead Sciences (GILD - Research Report), with a price target of $68.00. The company's shares closed yesterday at $65.00.Risinger covers the Healthcare sector, focusing on stocks such as Sanofi, Pfizer, and Eli Lilly & Co. According to TipRanks, Risinger has an average return of 8.2% and a 41.94% success rate on recommended stocks. Gilead Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $72.43, which is an 11.43% upside from current levels.
https://www.tipranks.com/news/blurbs/svb-securities-keeps-their-hold-rating-on-gilead-sciences-gild?utm_source=advfn.com&utm_medium=referral
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Gilead Sciences Charts.